Clene (CLNN) vs Talphera (TLPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Talphera (TLPH) has outperformed Clene (CLNN) over the past year, losing 16.7% versus a loss of 56.8%. Over five years, TLPH leads with a -94.9% price change compared with -96.8% for CLNN. Clene is the larger company by market cap ($55.7 million vs $54.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLNN | TLPH |
|---|---|---|
| Share price | $3.92 | $1.05 |
| Market cap | $55.72M | $54.50M |
| 1-day change | +1.29% | -5.41% |
| YTD return | -33.22% | -7.89% |
| 1-year return | -56.78% | -16.67% |
| 5-year return | -96.82% | -94.85% |
| EPS (TTM) | $-3.52 | $-0.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.50 | $1.57 |
| 52-week low | $3.25 | $0.69 |
| Distance from 52-week high | -70.96% | -33.12% |
| Average volume | 100.64K | 251.36K |
| Shares outstanding | 14.21M | 51.91M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TLPH has outperformed CLNN by 40.1 percentage points over the past year.
CLNN vs TLPH FAQ
Which is bigger, Clene or Talphera?
Clene (CLNN) is larger, with a market capitalization of $55.72M compared with $54.50M for Talphera (TLPH).
Which stock has performed better over the past year, CLNN or TLPH?
TLPH returned -16.67% over the past 12 months, compared with -56.78% for CLNN (price return, excluding dividends). Past performance does not predict future results.
Are Clene and Talphera in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.